Evangelos N. Symeonidis

Dr. Evangelos N. Symeonidis

Department of Urology II, European Interbalkan Medical Center, Thessaloníki, Kentrikí Makedonía, Greece
+1
orcid
Consultant Urological Surgeon | MD MSc FEBU | Assoc.Board Me...

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2023 in Genes
Verified
Journal Article
Open access
PDF file
Aris KaltsasAris Kaltsas
Aris Kaltsas
EMEfthalia Moustakli
Efthalia Moustakli
Konstantinos ATHANASIOS ZIKOPOULOSKonstantinos ATHANASIOS ZIKOPOULOS
Konstantinos ATHANASIOS ZIKOPOULOS
Ioannis GeorgiouIoannis Georgiou
Ioannis Georgiou
Fotios DimitriadisFotios Dimitriadis
Fotios Dimitriadis
ATHANASIOS ZACHARIOUATHANASIOS ZACHARIOU
ATHANASIOS ZACHARIOU
The average age of fathers at first pregnancy has risen significantly over the last decade owing to various variables, including a longer life expectancy, more access to contraception, later marriage, and other factors. As has been proven in several studies, women over 35 years of age have an increased risk of infertility, pregnancy problems, spontaneous abortion, congenital malformations, and postnatal issues. There are varying opinions on whether a father’s age affects the quality of his sperm or his ability to father a child. First, there is no single accepted definition of old age in a father. Second, much research has reported contradictory findings in the literature, particularly concerning the most frequently examined criteria. Increasing evidence suggests that the father’s age contributes to his offspring’s higher vulnerability to inheritable diseases. Our comprehensive literature evaluation shows a direct correlation between paternal age and decreased sperm quality and testicular function. Genetic abnormalities, such as DNA mutations and chromosomal aneuploidies, and epigenetic modifications, such as the silencing of essential genes, have all been linked to the father’s advancing years. Paternal age has been shown to affect reproductive and fertility outcomes, such as the success rate of in vitro fertilisation (IVF), intracytoplasmic sperm injection (ICSI), and premature birth rate. Several diseases, including autism, schizophrenia, bipolar disorders, and paediatric leukaemia, have been linked to the father’s advanced years. Therefore, informing infertile couples of the alarming correlations between older fathers and a rise in their offspring’s diseases is crucial, so that they can be effectively guided through their reproductive years.

Verified
Journal Article
Open access
PDF file
Aris KaltsasAris Kaltsas
Aris Kaltsas
AZAthanasios Zikopoulos
Athanasios Zikopoulos
Fotios DimitriadisFotios Dimitriadis
Fotios Dimitriadis
DSDanja Sheshi
Danja Sheshi
MPMagdalena Politis
Magdalena Politis
ATHANASIOS ZACHARIOUATHANASIOS ZACHARIOU
ATHANASIOS ZACHARIOU
Erectile dysfunction (ED) is a prevalent condition affecting men’s sexual health, with oxidative stress (OS) having recently been identified as a significant contributing causative factor. This narrative review aims to elucidate the role of OS in the pathophysiology of ED, focusing on impact, mechanisms, and potential therapeutic interventions. Key findings indicate that OS disrupts endothelial function and nitric oxide (NO) signaling, crucial for erectile function. Various sources of reactive oxygen species (ROS) and their detrimental effects on penile tissue are discussed, including aging, diabetes mellitus, hypertension, hyperlipidemia, smoking, obesity, alcohol consumption, psychological stress, hyperhomocysteinemia, chronic kidney disease, and sickle cell disease. Major sources of ROS, such as NADPH oxidase, xanthine oxidase, uncoupled endothelial NO synthase (eNOS), and mitochondrial electron transport, are identified. NO is scavenged by these ROS, leading to endothelial dysfunction characterized by reduced NO availability, impaired vasodilation, increased vascular tone, and inflammation. This ultimately results in ED due to decreased blood flow to penile tissue and the inability to achieve or maintain an erection. Furthermore, ROS impact the transmission of nitrergic neurotransmitters by causing the death of nitrergic neurons and reducing the signaling of neuronal NO synthase (nNOS), exacerbating ED. Therapeutic approaches targeting OS, including antioxidants and lifestyle modifications, show promise in ameliorating ED symptoms. The review underscores the need for further research to develop effective treatments, emphasizing the interplay between OS and vascular health in ED. Integrating pharmacological and non-pharmacological strategies could enhance clinical outcomes for ED patients, advocating for OS management in ED treatment protocols to improve patient quality of life.

17 January 2025 in Genes
Verified
Journal Article
Open access
PDF file
Aris KaltsasAris Kaltsas
Aris Kaltsas
EMEleftheria Markou
Eleftheria Markou
MKMaria-Anna Kyrgiafini
Maria-Anna Kyrgiafini
AZAthanasios Zikopoulos
Athanasios Zikopoulos
Evangelos N. SymeonidisEvangelos N. Symeonidis
Evangelos N. Symeonidis
MCMichael Chrisofos
Michael Chrisofos
Male reproductive health is governed by an intricate interplay of genetic, epigenetic, and environmental factors. Epigenetic mechanisms—encompassing DNA methylation, histone modifications, and non-coding RNA activity—are crucial both for spermatogenesis and sperm maturation. However, oxidative stress, driven by excessive reactive oxygen species, disrupts these processes, leading to impaired sperm function and male infertility. This disruption extends to epigenetic modifications, resulting in abnormal gene expression and chromatin remodeling that compromise genomic integrity and fertilization potential. Importantly, oxidative-stress-induced epigenetic alterations can be inherited, affecting the health and fertility of offspring and future generations. This review investigates how oxidative stress influences epigenetic regulation in male reproduction by modifying DNA methylation, histone modifications, and non-coding RNAs, ultimately compromising spermatogenesis. Additionally, it discusses the transgenerational implications of these epigenetic disruptions and their potential role in hereditary infertility and disease predisposition. Understanding these mechanisms is vital for developing therapeutic strategies that mitigate oxidative damage and restore epigenetic homeostasis in the male germline. By integrating insights from molecular, clinical, and transgenerational research, this work emphasizes the need for targeted interventions to enhance male reproductive health and prevent adverse outcomes in progeny. Furthermore, elucidating the dose–response relationships between oxidative stress and epigenetic changes remains a critical research priority, informing personalized diagnostics and therapeutic interventions. In this context, future studies should adopt standardized markers of oxidative damage, robust clinical trials, and multi-omic approaches to capture the complexity of epigenetic regulation in spermatogenesis. Such rigorous investigations will ultimately reduce the risk of transgenerational disorders and optimize reproductive health outcomes.

1 January 2016 in Physical Therapy in Sport
Verified
Journal Article
Closed access
Konstantinos TsikopoulosKonstantinos Tsikopoulos
Konstantinos Tsikopoulos
ITIoannis Tsikopoulos
Ioannis Tsikopoulos
Evangelos N. SymeonidisEvangelos N. Symeonidis
Evangelos N. Symeonidis
EPEfthymia Papathanasiou
Efthymia Papathanasiou
AHAnna-Bettina Haidich
Anna-Bettina Haidich
KNKonstantinos Natsis
Konstantinos Natsis

15 October 2023 in Medicina
Verified
Journal Article
Open access
PDF file
Aris KaltsasAris Kaltsas
Aris Kaltsas
Fotios DimitriadisFotios Dimitriadis
Fotios Dimitriadis
DZDimitrios Zachariou
Dimitrios Zachariou
AZAthanasios Zikopoulos
Athanasios Zikopoulos
Evangelos N. SymeonidisEvangelos N. Symeonidis
Evangelos N. Symeonidis
ATHANASIOS ZACHARIOUATHANASIOS ZACHARIOU
ATHANASIOS ZACHARIOU
Infertility is a global health concern, with male factors playing an especially large role. Unfortunately, however, the contributions made by reproductive urologists in managing male infertility under assisted reproductive technology (ART) often go undervalued. This narrative review highlights the important role played by reproductive urologists in diagnosing and treating male infertility as well as any barriers they face when providing services. This manuscript presents a comprehensive review of reproductive urologists’ role in managing male infertility, outlining their expertise in diagnosing and managing male infertility as well as reversible causes and performing surgical techniques such as sperm retrieval. This manuscript investigates the barriers limiting urologist involvement such as limited availability, awareness among healthcare professionals, and financial constraints. This study highlights a decrease in male fertility due to lifestyle factors like sedentary behavior, obesity, and substance abuse. It stresses the significance of conducting an evaluation process involving both male and female partners to identify any underlying factors contributing to infertility and to identify patients who do not require any interventions beyond ART. We conclude that engaging urologists more effectively in infertility management is key to optimizing fertility outcomes among couples undergoing assisted reproductive technology treatments and requires greater education among healthcare providers regarding the role urologists and lifestyle factors that could have an effect on male fertility.

27 September 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
Evangelos N. SymeonidisEvangelos N. Symeonidis
Evangelos N. Symeonidis
EEEVANGELINI CRYOPRESERVATION EVGENI
EVANGELINI CRYOPRESERVATION EVGENI
VPVasileios Palapelas
Vasileios Palapelas
DKDimitra Koumasi
Dimitra Koumasi
NPNikolaos Pyrgidis
Nikolaos Pyrgidis
Fotios DimitriadisFotios Dimitriadis
Fotios Dimitriadis
Male infertility, a relatively common and multifactorial medical condition, affects approximately 15% of couples globally. Based on WHO estimates, a staggering 190 million people struggle with this health condition, and male factor is the sole or contributing factor in roughly 20–50% of these cases. Nowadays, urologists are confronted with a wide spectrum of conditions ranging from the typical infertile male to more complex cases of either unexplained or idiopathic male infertility, requiring a specific patient-tailored diagnostic approach and management. Strikingly enough, no identifiable cause in routine workup can be found in 30% to 50% of infertile males. The medical term male oxidative stress infertility (MOSI) was recently coined to describe infertile men with abnormal sperm parameters and oxidative stress (OS), including those previously classified as having idiopathic infertility. OS is a critical component of male infertility, entailing an imbalance between reactive oxygen species (ROS) and antioxidants. ROS abundance has been implicated in sperm abnormalities, while the exact impact on fertilization and pregnancy has long been a subject of considerable debate. In an attempt to counteract the deleterious effects of OS, urologists resorted to antioxidant supplementation. Mounting evidence indicates that indiscriminate consumption of antioxidants has led in some cases to sperm cell damage through a reductive-stress-induced state. The “antioxidant paradox”, one of the biggest andrological challenges, remains a lurking danger that needs to be carefully avoided and thoroughly investigated. For that reason, oxidation-reduction potential (ORP) emerged as a viable ancillary tool to basic semen analysis, measuring the overall balance between oxidants and antioxidants (reductants). A novel biomarker, the Male infertility Oxidative System (MiOXSYS®), is a paradigm shift towards that goal, offering a quantification of OS via a quick, reliable, and reproducible measurement of the ORP. Moderation or “Μέτρον” according to the ancient Greeks is the key to successfully safeguarding redox balance, with MiOXSYS® earnestly claiming its position as a guarantor of homeostasis in the intracellular redox milieu. In the present paper, we aim to offer a narrative summary of evidence relevant to redox regulation in male reproduction, analyze the impact of OS and reductive stress on sperm function, and shed light on the “antioxidant paradox” phenomenon. Finally, we examine the most up-to-date scientific literature regarding ORP and its measurement by the recently developed MiOXSYS® assay.